Related Experiment Video
Updated: May 27, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells
Jessica J Miciak1,2, Lucy Petrova1, Rhythm Sajwan1
1Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.
Abstract:
Cancers that retain wild type TP53 presumably harbor other clonal alterations that permitted their precursors to bypass p53-mediated growth suppression. Consequently, studies that employ TP53-wild type cancer cells and their isogenic derivatives may systematically fail to appreciate the full scope of p53 functionality. Several TP53 phenotypes are known to be absent in the widely used isogenic HCT116 colorectal cancer (CRC) model, which originated from a tumor that had retained wild type TP53. In contrast, we show that restoration of p53 in the TP53-mutant CRC cell line DLD-1 impeded cell proliferation, increased levels of senescence and sensitized cells to ionizing radiation (IR). To study p53 in a non-cancer context, we disrupted TP53 in hTERT-RPE1 cells. Derived from primary cells that were immortalized in vitro, hTERT-RPE1 expressed striking p53-dependent phenotypes and appeared to select for p53 loss during routine culture. hTERT-RPE1 expressed a p53-responsive transcriptome that was highly representative of diverse experimental systems. We discovered several novel downstream p53 targets of potential clinical relevance including ALDH3A1, which is involved in the detoxification of aldehydes and the metabolism of reactive oxygen species, and nectin cell adhesion molecule 4 (NECTIN4) which encodes a secreted surface protein that is overexpressed in many tumors.
Insights
Restoring wild-type p53 in cancer cells impedes proliferation and increases sensitivity to radiation. Studying p53 in normal cells reveals novel targets like ALDH3A1 and NECTIN4, crucial for understanding tumor suppression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Wild-type TP53 is often lost in cancers, hindering studies on its full tumor-suppressive functions.
- Commonly used cancer models with wild-type TP53 may not fully represent p53's capabilities.
- Previous models like HCT116 colorectal cancer (CRC) cells, despite wild-type TP53, lack certain p53 phenotypes.
Purpose of the Study:
- To investigate the functional impact of restoring wild-type p53 in TP53-mutant colorectal cancer cells.
- To explore p53-dependent phenotypes in a non-cancerous cell line (hTERT-RPE1) to understand p53's broader roles.
- To identify novel p53 target genes with potential clinical significance in cancer.
Main Methods:
- Restoration of p53 in the TP53-mutant DLD-1 CRC cell line.
- Disruption of TP53 in immortalized hTERT-RPE1 cells.
- Analysis of p53-dependent phenotypes including cell proliferation, senescence, and response to ionizing radiation (IR).
- Transcriptomic analysis to identify p53-responsive genes.
Main Results:
- Restoring p53 in DLD-1 cells reduced proliferation, induced senescence, and increased sensitivity to IR.
- TP53 disruption in hTERT-RPE1 cells revealed significant p53-dependent phenotypes, suggesting p53 loss is selected for during culture.
- A p53-responsive transcriptome in hTERT-RPE1 cells was identified, serving as a model for diverse experimental systems.
- Novel p53 targets, including ALDH3A1 (aldehyde detoxification, ROS metabolism) and NECTIN4 (cell adhesion, overexpressed in tumors), were discovered.
Conclusions:
- Wild-type p53 actively suppresses tumor growth and enhances treatment sensitivity.
- The hTERT-RPE1 cell line is a valuable model for studying p53 function and identifying novel targets.
- ALDH3A1 and NECTIN4 represent potential therapeutic targets due to their roles in detoxification, metabolism, and their prevalence in tumors.
Related Concept Videos
Telomeres and Telomerase
Abnormal Proliferation
Replicative Cell Senescence
DNA Damage can Stall the Cell Cycle
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

